Blake Insomnia Therapeutics, Inc.

244, 5th Avenue
Suite A-154
New York
New York
10001
United States

Tel: 888-612-2905

Email: help@blakeinsomnia.com

Show jobs for this employer

About Blake Insomnia Therapeutics, Inc.

Blake Insomnia Therapeutics, Inc. is a New York-based pharmaceutical company devoted to improving nighttime and daytime quality of life for people with insomnia. Our patent-pending compound, Zleepax™ (ZLX-1), has demonstrated efficacy without causing side effects identified as the No. 1 problem with current sleep medication. Blake Insomnia completed its reverse merger into NASDAQ OTC in second half of 2015.
YEAR FOUNDED:
2012
LEADERSHIP:
Founder and CEO: Birger Jan Olsen